These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
426 related items for PubMed ID: 2538547
1. Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis. Fenouillet E, Clerget-Raslain B, Gluckman JC, Guétard D, Montagnier L, Bahraoui E. J Exp Med; 1989 Mar 01; 169(3):807-22. PubMed ID: 2538547 [Abstract] [Full Text] [Related]
2. Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1. Fenouillet E, Gluckman JC, Bahraoui E. J Virol; 1990 Jun 01; 64(6):2841-8. PubMed ID: 2335819 [Abstract] [Full Text] [Related]
3. Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Matthews TJ, Weinhold KJ, Lyerly HK, Langlois AJ, Wigzell H, Bolognesi DP. Proc Natl Acad Sci U S A; 1987 Aug 01; 84(15):5424-8. PubMed ID: 3037551 [Abstract] [Full Text] [Related]
4. N-linked oligosaccharides of simian immunodeficiency virus envelope glycoproteins are dispensable for the interaction with the CD4 receptor. Benjouad A, Babas T, Montagnier L, Bahraoui E. Biochem Biophys Res Commun; 1993 Jan 29; 190(2):311-9. PubMed ID: 8427576 [Abstract] [Full Text] [Related]
8. A rapid solution immunoassay to quantify binding of the human immunodeficiency virus envelope glycoprotein to soluble CD4. McQuade TJ, Pitts TW, Tarpley WG. Biochem Biophys Res Commun; 1989 Aug 30; 163(1):172-6. PubMed ID: 2549987 [Abstract] [Full Text] [Related]
11. Processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1 in the presence of trimming glucosidase inhibitor deoxynojirimycin. Pal R, Kalyanaraman VS, Hoke GM, Sarngadharan MG. Intervirology; 1989 Aug 30; 30(1):27-35. PubMed ID: 2542177 [Abstract] [Full Text] [Related]
12. Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport. Dewar RL, Vasudevachari MB, Natarajan V, Salzman NP. J Virol; 1989 Jun 30; 63(6):2452-6. PubMed ID: 2542563 [Abstract] [Full Text] [Related]
14. 95- and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein gp120 bind to the CD4 receptor. Nygren A, Bergman T, Matthews T, Jörnvall H, Wigzell H. Proc Natl Acad Sci U S A; 1988 Sep 30; 85(17):6543-6. PubMed ID: 2842778 [Abstract] [Full Text] [Related]
15. Intracellular membrane traffic of human immunodeficiency virus type 1 envelope glycoproteins: vpu liberates Golgi-targeted gp160 from CD4-dependent retention in the endoplasmic reticulum. Kimura T, Nishikawa M, Ohyama A. J Biochem; 1994 May 30; 115(5):1010-20. PubMed ID: 7961587 [Abstract] [Full Text] [Related]
17. [HIV envelope proteins are bound by human epidermal Langerhans cells by a binding site which differs from the site on the CD4 molecule, and are internalized by receptor endocytosis]. Schmitt D, Dezutter-Dambuyant C, Hanau D, Schmitt DA, Kolbe HV, Kieny MP, Cazenave JP, Thivolet J. C R Acad Sci III; 1989 May 30; 308(10):269-75. PubMed ID: 2543485 [Abstract] [Full Text] [Related]
18. Characterization of CD4 glycoprotein determinant-HIV envelope protein interactions: perspectives for analog and vaccine development. Farrar WL, Harel-Bellan A, Ferris DK. Crit Rev Immunol; 1988 May 30; 8(4):315-39. PubMed ID: 2850890 [Abstract] [Full Text] [Related]
20. Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesis. Robinson WE, Montefiori DC, Mitchell WM. AIDS Res Hum Retroviruses; 1987 May 30; 3(3):265-82. PubMed ID: 2829950 [Abstract] [Full Text] [Related] Page: [Next] [New Search]